Brain Disorders & Therapy

Bright F, Werry EL, Dobson-Stone C, Piguet O, Ittner LM, Halliday GM, et al. Neuroinflammation in frontotemporal dementia. Nature Reviews Neurology. 2019:540-55.

Brookes KJ, Morgan K. Genetics of A lzheimer's Disease. eLS. 2001:1-6.

Yoon S, Kim YK. The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer's disease.

Gao L, Jiang T, Yao X, Yu L, Yang X, Li Y. TREM2 and the Progression of Alzheimer's Disease. Current neurovascular research. 2017 ;14:177-83.

Dong Y, Li X, Cheng J, Hou L. Drug development for Alzheimer’s disease: Microglia induced neuroinflammation as a target?. International journal of molecular sciences. 2019;20:558.

Thomas MH, Paris C, Magnien M, Colin J, Pelleïeux S, Coste F, et al. Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA 2 balance. Alzheimer's research & therapy. 2017;9:69.

Rehker J, Rodhe J, Nesbitt RR, Boyle EA, Martin BK, Lord J, K et al. Caspase-8, association with Alzheimer’s Disease and functional analysis of rare variants. PloS one. 2017;12.

Wang P, Guo Q, Zhou Y, Chen K, Xu Y, Ding D, et al. Lack of association between triggering receptor expressed on myeloid cells 2 polymorphism rs75932628 and late-onset Alzheimer’s disease in a Chinese Han population. Psychiatric genetics. 2018;28:16.

Brosseron F, Traschütz A, Widmann CN, Kummer MP, Tacik P, Santarelli F, et al. Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease. Alzheimer's research & therapy. 2018;10:25.

Suárez-Calvet M, Morenas-Rodríguez E, Kleinberger G, Schlepckow K, Caballero MÁ, Franzmeier N, Capell A, Fellerer K, Nuscher B, Eren E, Levin J. Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology. Molecular neurodegeneration. 2019;14(1.

López-López A, Gelpi E, Lopategui DM, Vidal-Taboada JM. Association of the CX3CR1-V249I variant with neurofibrillary pathology progression in late-onset Alzheimer’s disease. Molecular neurobiology. 2018;55:2340-9.

Li JT, Zhang Y. TREM2 regulates innate immunity in Alzheimer’s disease. Journal of neuroinflammation. 2018;15:107.

Lopez Gonzalez I, Garcia-Esparcia P, Llorens F, Ferrer I. Genetic and transcriptomic profiles of inflammation in neurodegenerative diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and tauopathies. International journal of molecular sciences. 2016;17:206.

Jay TR, von Saucken VE, Landreth GE. TREM2 in neurodegenerative diseases. Molecular neurodegeneration. 2017;12:56.

Sims R, Van Der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature genetics. 2017;49:1373.

Khadijah B. Research & Reviews: Journal of Medical and Health Sciences.

Increasing dietary tryptophan in conjunction with decreasing other large neutral amino acids increases weight gain and feed intake in weaner pigs regardless of experimental infection with enterotoxigenic Escherichia coli Uppari DJ. Research and Reviews: Journal of Medical and Health Sciences.

Butt RL, Volkoff H. Gut Microbiota and Energy Homeostasis in Fish. Gut microbiota and energy homeostasis in fish

Dynamic changes in microbial community structure in farming pond water and their effect on the intestinal microbial community profile in juvenile common carp (Cyprinus carpio L.) Volkoff H, Butt RL. Gut microbiota and energy homeostasis in fish. Frontiers in endocrinology. 2019;10:9.

Martin GP, McDonald KR, Allsop D, Diggle PJ, Leroi I. Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis. Journal of Neurology. 2019:1-4.